Human Xtensions Stock EBITDA

HUMX Stock  ILA 29.10  0.20  0.69%   
Human Xtensions fundamentals help investors to digest information that contributes to Human Xtensions' financial success or failures. It also enables traders to predict the movement of Human Stock. The fundamental analysis module provides a way to measure Human Xtensions' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Human Xtensions stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Human Xtensions Company EBITDA Analysis

Human Xtensions' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Human Xtensions EBITDA

    
  (45.95 M)  
Most of Human Xtensions' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Human Xtensions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, Human Xtensions reported earnings before interest,tax, depreciation and amortization of (45.95 Million). This is 105.24% lower than that of the Healthcare sector and 107.15% lower than that of the Medical Devices industry. The ebitda for all Israel stocks is 101.18% higher than that of the company.

Human EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Human Xtensions' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Human Xtensions could also be used in its relative valuation, which is a method of valuing Human Xtensions by comparing valuation metrics of similar companies.
Human Xtensions is one of the top stocks in ebitda category among its peers.

Human Fundamentals

About Human Xtensions Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Human Xtensions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Human Xtensions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Human Xtensions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Human Stock

Human Xtensions financial ratios help investors to determine whether Human Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Human with respect to the benefits of owning Human Xtensions security.